Terry Dagnon

Track

Insider profile

Currently holds a position at Outlook Therapeutics Inc

Performance

Overall performance
1.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -28% 8.2% 15.1%
Success rate 22% 68% 82%
Transactions
6 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -14%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Operating Officer Outlook Therapeutics Inc Nov. 30, 2018 -
Terry Dagnon's trades of Outlook Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
98.75
Quantity 39,392 -49.7%
Value US$3,393,420
Transaction date
Purchase
Price
308.22
Quantity 89,066 +36.3%
Value US$3,599,577
Transaction date
Purchase
Price
1.42
Quantity 10,000 +0.9%
Value US$14,200
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-04-21 2023-04-20
S Sale
41,472 +41.7%
449.28
US$4,947,834 		41,472 +41.7% 449.28 US$4,947,834
2022-06-23 2022-06-21
B Purchase
39,392 -49.7%
98.75
US$3,393,420 		39,392 -49.7% 98.75 US$3,393,420
2021-12-06 2021-12-06
B Purchase
89,066 +36.3%
308.22
US$3,599,577 		89,066 +36.3% 308.22 US$3,599,577
2021-12-03 2021-12-03
B Purchase
10,000 +0.9%
1.42
US$14,200 		10,000 +0.9% 1.42 US$14,200
2021-02-25 2021-02-23
S Sale
15,900 -1.4%
2.09
US$33,199 		15,900 -1.4% 2.09 US$33,199
2021-02-17 2021-02-12
S Sale
63,700 -5.3%
2.55
US$162,435 		63,700 -5.3% 2.55 US$162,435